Opinions from pharmacy owners and LPCs across the country are being compiled, alongside inputs from national pharmacy organisations and results from ongoing sector polling, to inform Community Pharmacy England Committee discussions on negotiating priorities for 2026/27. The Committee will consider all inputs, alongside Community Pharmacy England’s own analysis, to inform positioning and objectives for the
Read moreFollowing representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the following July 2025 concessionary prices: Drug Pack size Previous price concession for July 2025 New price concession for July 2025 Fexofenadine 180mg tablets 30 £2.31 £4.10 Pioglitazone 45mg tablets 28 £25.25
Read moreMHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours transdermal patches MSN/2025/048 Tier 2 – medium impact Date of issue: 06/08/2025 Progynova® TS 50micrograms/24hours and 100micrograms/24hours transdermal patches (once weekly estradiol patches) will be discontinued from late December 2025 and
Read moreMHRA Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma Drug alert number: EL(25)A/38 Date issued: 04 August 2025 LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing. DMRC reference number: DMRC-36306427 Company name: LEO
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 August 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Hydrocortisone 500microgram granules in capsules for opening Alkindi® 0.5 mg granules in capsules
Read moreChanges are being made to the Manage Your Service (MYS) pharmacy portal, aimed at improving user experience. The new-look portal will be launched on Thursday 21 August 2025. Please note: the MYS portal will be temporarily unavailable between 7:00am to 8:30am on Thursday 21 August 2025 whilst NHS Business Services Authority (NHSBSA) make the changes. What’s
Read moreThe Department of Health and Social Care (DHSC) has today (31/07/2025) confirmed the following final list of price concessions for July 2025. Drug Pack size Price concession Acetazolamide 250mg tablets 112 £60.90 Amiodarone 100mg tablets 28 £2.02 Buprenorphine 8mg sublingual tablets sugar free 7 £5.05 Carbocisteine 250mg/5ml oral solution 300 £4.99 Carbocisteine 375mg capsules 120 £2.75
Read moreMHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) Date issued: 31 July 2025 Drug Alert Number: EL(25)A/37 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL. DMRC reference number: DMRC-34866997 Marketing Authorisation
Read moreNational Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment National Patient Safety Alert Reference Number: NatPSA/2025/004/MVA Date issued: 29 July 2025 Explanation of identified issue: The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025: Rifampicin 150mg and 300mg capsules Rifampicin
Read more
